CHD Stock Forecast & Price Target

Church & Dwight Co is supported by a resilient portfolio of leading power brands, with Arm & Hammer, Batiste, OxiClean, Hero, and TheraBreath driving roughly 70% of annual sales and profits while the U.S. still contributes about 80% of revenue. Its 3Q organic sales growth of 5.1% beat the 3% guide on 4.6% volume growth, reflecting innovation, distribution gains, and stronger category share in laundry, oral care, and cat litter, while margin expansion was helped by benign costs and operating leverage. The added Touchland and Miss Mouth brands, plus ongoing M&A optionality and a leverage ratio of 1.5, reinforce a long runway for continued growth and earnings compounding.

Church & Dwight Co is viewed negatively because its business and category growth have slowed below historical rates amid weaker consumer demand, leaving little evidence of a near-term U.S. inflection and limited exposure to higher-growth international markets. Touchland’s expected flat performance in 2026 versus prior high-teens expectations underscores execution risk, while intense competition, private-label pressure, and heavy promotional activity could erode share across its core brands. The stock also carries valuation risk given its premium to peers, and downside cases point to only ~1.2% top-line CAGR, peak margins near 19%, and further pressure from input-cost volatility and acquisition execution risk.